EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Clinical trials for EXTENSIVE-STAGE SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE-STAGE SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for EXTENSIVE-STAGE SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for aggressive lung cancer: drug combo tested in major trial
Disease control Not yet recruitingThis study tests a new drug called BL-B01D1 combined with tislelizumab against standard chemotherapy plus tislelizumab for people with extensive-stage small cell lung cancer who have not had treatment before. About 562 adults will take part to see which combination helps them liv…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 01:04 UTC
-
Engineered immune cells take aim at deadliest lung cancer
Disease control Not yet recruitingThis early-stage study tests a personalized cell therapy for people with advanced small cell lung cancer or similar neuroendocrine tumors that have stopped responding to standard treatment. Researchers take a patient's own immune cells, modify them in the lab to recognize a prote…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 00:53 UTC
-
New combo aims to keep advanced lung cancer in check
Disease control Not yet recruitingThis study tests whether a combination of two drugs (lurbinectedin and durvalumab) can help keep extensive-stage small-cell lung cancer from growing after initial chemotherapy. About 50 adults whose cancer did not worsen after first treatment will receive this maintenance therapy…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New hope for tough lung cancer: drug duo targets tumors after first treatment fails
Disease control Not yet recruitingThis study tests a combination of two drugs, sacituzumab tirumotecan and anlotinib, in 30 adults with extensive-stage small cell lung cancer that got worse after initial treatment. The goal is to see if the combo can shrink tumors or slow the cancer. Participants must have tried …
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: China Medical University, China • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Lung cancer study watches real treatments, no new drugs
Knowledge-focused Not yet recruitingThis study observes how patients with advanced small cell lung cancer are treated in everyday hospital settings and how they respond. About 96 adults will join, and researchers will collect data from medical records and regular check-ins every 3 months. No experimental treatments…
Matched conditions: EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 00:50 UTC